Abstract Cellulose synthase-like proteins in the D family share high levels of sequence identity with the cellulose synthase proteins and also contain the processive -glycosyltransferase motifs conserved among all members of the cellulose synthase superfamily. Consequently, it has been hypothesized that members of the D family function as either cellulose synthases or glycan synthases involved in the formation of matrix polysaccharides. As a prelude to understanding the function of proteins in the D family, we sought to determine where they are located in the cell. A polyclonal antibody against a peptide located at the N-terminus of the Arabidopsis D2 cellulose synthase-like protein was generated and puriWed. After resolving Golgi vesicles from plasma membranes using endomembrane puriWcation techniques including two-phase partitioning and sucrose density gradient centrifugation, we used antibodies against known proteins and marker enzyme assays to characterize the various membrane preparations. The Arabidopsis cellulose synthase-like D2 protein was found mostly in a fraction that was enriched with Golgi membranes. In addition, versions of the Arabidopsis cellulose synthase-like D2 proteins tagged with a green Xuorescent protein was observed to colocalize with a DsRed-tagged Golgi marker protein, the rat alpha-2,6-sialyltransferase. Therefore, we postulate that the majority of Arabidopsis cellulose synthase-like D proteins, under our experimental conditions, are likely located at the Golgi membranes. Furthermore, protease digestion of Golgi-rich vesicles revealed almost complete loss of reaction with the antibodies, even without detergent treatment of the Golgi vesicles. Therefore, the N-terminus of the Arabidopsis cellulose synthase-like D2 protein likely faces the cytosol. Combining this observation with the transmembrane domain predictions, we postulate that the large hydrophilic domain of this protein also faces the cytosol.
Introduction
CSLD proteins constitute a group belonging to the cellulose synthase superfamily of proteins. Members of this group have the highest sequence similarity to CESA proteins within the cellulose synthase superfamily, showing sequence identities of 40-45% . CSLD proteins are also similar in size to CESA proteins and have a similar number and organization of predicted transmembrane domains . Moreover, CSLD and CESA proteins share structural features that may be indicative of processive glycosyltransferases (Saxena et al. 1995) , such as the D,D,D,Q££RW motif proposed to deWne the nucleotidesugar binding domain and the catalytic site (Richmond and Somerville 2000) of the cellulose synthases. Both CSLD and CESA proteins belong to family 2 of inverting nucleotide-diphospho-sugar glycosyltransferases, which synthesize polysaccharides containing repeating -glycosyl units (Campbell et al. 1997; Richmond and Somerville 2001) .
Pinpointing the localization of CSLD proteins may shine some light on their putative functions, because eVorts to identify their biochemical function through heterologous expression and enzymatic activity assays have not been successful to date (Liepman et al. 2005) . If CSLD proteins are truly cellulose synthase isoforms, they might exhibit a localization pattern similar to CESA. If CSLD proteins are involved in the biosynthesis of other matrix polysaccharides, they might be expected to have a diVerent localization pattern than CESA proteins and reside on the Golgi membranes, as other matrix polysaccharides are thought to be synthesized in Golgi complexes and then transported to the cell surface via membrane-bound vesicles for incorporation into the wall matrix (Delmer and Stone 1988) .
AtCSLD3 protein was localized to the endoplasmic reticulum (ER) when Favery et al. transiently expressed a C-terminal tagged AtCSLD3-GFP fusion protein in Nicotiana benthamiana leaf cells (Favery et al. 2001 ). This ER localization of AtCSLD3 protein was seen again by Bernal et al. when a GFP tag was placed at the C-terminus of AtCSLD3 or AtCSLD5 (Bernal et al. 2007 ). However, when the GFP tag was placed at the N-terminus of AtCSLD5 or AtCSLD3, both the fusion proteins were localized to the Golgi apparatus (Bernal et al. 2007 ). Furthermore, a proteomic approach using the isotope-tagging technique to localize organelle proteins also identiWed AtCSLD3 in the Golgi apparatus (Dunkley et al. 2006) . To further investigate the localization of AtCSLD proteins, we used a biochemical approach to fractionate cellular organelles and localized AtCSLD2 proteins to the Golgi fraction by means of an AtCSLD2-speciWc antibody. We substituted the predicted non-transmembrane hydrophilic domain of AtCSLD2 with a GFP tag and visualized the fusion proteins in the Golgi apparatus as well.
The current working model predicts that Golgi-localized glycosyltransferases involved in wall matrix polysaccharide biosynthesis catalyze their speciWc reactions inside the Golgi lumen, with their catalytic domains facing the lumen and their sugar nucleotide substrates being transported into the Golgi from the cytosol (Northcote and Pickett-Heaps 1966; Zhang and Staehelin 1992; Norambuena et al. 2002) . More recent topology studies of such glycosyltransferases include the protection of enzyme activities from protease treatment by the Golgi membranes, for the -1, 4-galacturonosyltransferase involved in the biosynthesis of homogalacturonan (Sterling et al. 2001) , and the -1, 4-galactosyltransferase involved in the synthesis of -1, 4-galactan side chains in rhamnogalacturonan I (Geshi et al. 2004 ). On the other hand, the maize mixed linkage (1-3), (1-4)--D-glucan synthase was found to be sensitive to pretreatments of Golgi membranes with proteinase K (Urbanowicz et al. 2004) . Therefore, the topology of (1-3), (1-4)--D-glucan synthase was proposed to be more closely related to the cellulose synthase than to non-cellulosic glucan synthase or glycosyltransferases (Urbanowicz et al. 2004) . Generally, cellulose synthases located at the plasma membrane are predicted to have their active site facing the cytoplasmic side of the membrane (Kimura et al. 1999 ) and use sugar nucleotide substrates from the cytosol, incorporating them into cellulose on the other side of the plasma membrane.
Here, using similar proteinase protection assays, we present evidence that the N-terminus of AtCSLD2 protein is not protected by the un-solubilized Golgi membranes and therefore must be facing the cytosol. Combining this observation with predictions regarding the topology of AtCSLD2 in the membrane leads to the hypothesis that its putative large hydrophilic loop also faces the cytosol.
Materials and methods

Plant materials
Arabidopsis plants were grown under non-sterile hydroponic conditions (Gibeaut et al. 1997) in growth chambers in an 18 h/6 h light/dark cycle and light/dark temperature of 22°C/20°C. Arabidopsis (ecotype Columbia) embryonic suspension cell line T87-C33 (Axelos et al. 1992 ) was maintained in the dark at 25°C in suspension culture
¡1 thiamine-HCl, 1 M 2,4-D, and 1 mM K 2 HPO 4 , pH 5.7).
Preparation of total protein fraction and microsomal membranes from Arabidopsis plants Tissues from 5-week-old hydroponically grown Arabidopsis plants were ground in liquid nitrogen and resuspended in extraction buVer A (150 mM Tris HCl at pH 6.8, 3% SDS, 7.5% 2-mercaptoethanol) at 2 ml g ¡1 fresh weight. The extracts were boiled for 15 min and centrifuged for 15 min at 10,000g. The supernatants were saved as total protein fractions.
For microsomal membrane preparations, each 20-g sample of tissue from 5-week-old Arabidopsis plants was cut into small pieces with a Comfort Food Chopper (Zyliss, Switzerland) and ground with mortar and pestle on ice in 40 ml extraction buVer B (50 mM Hepes KOH, pH 6.5, 10 mM potassium acetate, 2.5 mM EDTA, 0.4 M sucrose, 1 mM DTT, 0.2 mM PMSF, 1% Protease Inhibitors [Sigma]). After passage through a double layer of miracloth, extracts were centrifuged at 10,000g for 10 min at 4°C. The pellet was resuspended in buVer B as the P10 fraction. The supernatant S10 fraction was subjected to further centrifugation at 100,000g for 1 h at 4°C. The supernatant from this step was the S100 fraction, and the pellet was resuspended in extraction buVer B, usually of one-tenth of the starting volume, as the P100 fraction.
Preparation of S10 protein fraction and microsomal membranes from Arabidopsis cell suspension cultures Arabidopsis suspension cells, cultured for 4 to 5 days were collected on miracloth using vacuum Wltration. Usually, 20 g of cells were suspended at a concentration of 1/3 g ml ¡1 of extraction buVer C (50 mM Hepes KOH, pH 6.5, 2 mM EDTA, 15% sucrose, 1 mM DTT, 0.2 mM PMSF, 1% Protease Inhibitors [Sigma] ). Cells were disrupted in a blender with short bursts of 10 s for a total of 1 min on ice. Cell lysate was Wltered through a double layer of miracloth and subjected to centrifugation at 10,000g for 10 min at 4°C. The supernatant was saved as the S10 protein fraction, and the pellet was discarded. The supernatant solution was then centrifuged at 100,000g for 1 h at 4°C to yield the S100 fraction, and a membrane pellet was resuspended in extraction buVer C at onetenth of the starting volume and labeled as the P100 fraction.
Solubilization of microsomal membrane proteins P100 microsomal fractions were isolated from either 5-week-old hydroponically grown Arabidopsis above-ground tissues or from 4-to 5-day-old Arabidopsis suspensioncultured cells. Equal amounts of P100 microsomal protein were resuspended in the same amount of extraction buVer C and incubated with equal volume of the same buVer containing 4 M Urea, 2 M NaCl, 0.2 M Na 2 CO 3 , 0.4% Triton X-100, 0.4% SDS or buVer C alone for 30 min on ice. After treatment, all solutions were centrifuged at 100,000g again for 1 h at 4°C. Supernatants were saved and the pellets were resuspended in the same volume of buVer C. Equal volumes of each fraction were used for SDS-PAGE and immunoblotting.
Sucrose density gradient fractionation of microsomal membranes
The S10 protein fraction isolated from Arabidopsis suspension-cultured cells was subjected to a two-step sequential sucrose gradient fractionation. The Wrst sucrose gradient was made in an SW28 centrifuge tube with two layers of 10 ml of buVer C, containing 50 and 15% of sucrose, respectively. The S10 protein fraction was loaded on top of the gradient and subjected to a centrifugation of 100,000g for 1 h at 4°C. The interface between the two sucrose solutions, which was about 2 ml in volume, was recovered and diluted with the buVer C lacking sucrose until the sucrose concentration reached between 25 and 30%. This diluted interface was used for the second centrifugation step. The second sucrose gradient, made in an SW40 centrifuge tube, was linear and contained 30-50% sucrose in buVer C. About 2.5 ml of the diluted interface from the Wrst step was laid on top of the linear gradient and centrifuged at 100,000g for 3 h at 4°C. Fractions of 800 l each were collected with an Auto Densi-Flow fractionator (Labconco). Sucrose concentrations were determined with a refractometer (American Optical Corporation, BuValo, NY).
Two-phase partitioning
The two-phase partitioning method for the puriWcation of plasma membranes was modiWed from a previous protocol (Larsson et al. 1987) . The crude microsomal membranes from suspension-cultured Arabidopsis cells (P100 pellet) were resuspended in buVer D (0.33 M sucrose, 3 mM KCl, 5 mM potassium phosphate at pH 7.8, Protease Inhibitors [1:100, Sigma]) in one-tenth of the starting volume of the S10 fraction. For every 3 g of this microsome solution, 9 g of buVer E (buVer D plus 8.4% Dextran T500 and 8.4% PEG 3350) was added to make a Wnal concentration of 6.3% of both Dextran and PEG. The tubes were inverted 30 times for mixing, and the samples were centrifuged at 1,500g for 5 min at 4°C in a swinging bucket rotor. The upper phase was collected as the U1 fraction, and the lower phase as the L1 fraction. BuVer F (buVer D plus 6.3% Dextran T500 and 6.3% PEG 3350) was prepared fresh and allowed to sit overnight at 4°C to separate the two phases. The U1 fraction was further extracted twice with equal volumes of the lower phase from buVer F to produce phases U2, L2Ј, U3, and L3Ј sequentially. The L1 fraction was also further extracted twice with equal volumes of the upper phase from buVer F, to produce the U2Ј, L2, U3Ј and L3 phases. Equal volumes of each phase or equal amounts of protein from each phase were used for SDS-PAGE and enzyme activity assays. Protein concentration was determined with a Micro BCA kit (Pierce, Rockford, IL, USA).
Preparation of Golgi-rich microsomal membrane fractions
The centrifugation procedure developed by Buckeridge et al. (1999) for maize was adopted for use with Arabidopsis. The S10 protein fraction was prepared from 4-to 5-day-old suspension-cultured cells, as described for other applications, except that buVer G (84% sucrose [w/v] , 20 mM Hepes KOH, pH 7.0, 20 mM KCl, 5 mM EDTA, 5 mM EGTA, 10 mM DTT, Protease Inhibitors [1:100, Sigma]) was used. The sucrose concentration in the S10 fraction was determined with a refractometer (American Optical Corporation, BuValo, NY) and adjusted to around 40% (37-45%) using buVer G containing no sucrose or 84% sucrose, depending on the need. Sucrose gradient was made in gradient buVer H containing 20 mM Hepes KCl, pH 7.0, Protease Inhibitors (1:100, Sigma), and various concentrations of sucrose.
To make a gradient, 10 ml of S10 total protein with adjusted sucrose concentration was laid on top of 5 ml of buVer H containing 50% (w/v) sucrose in an SW28 centrifuge tube. On top of the sample, we added sequentially buVer H: 8 ml with 34% (w/v) sucrose, 8 ml of 25% (w/v) sucrose, and 7 ml of 18% (w/v) sucrose. About 2 ml of buVer H containing 9.5% (w/v) sucrose was used to Wll the tube completely. This Wlled tube was centrifuged at 100,000g for 1.5 to 3 h at 4°C. After centrifugation, the interfaces between layers were collected and designated as fraction 1, 2, 3, 4, or 5 from the top to the bottom of the gradient. According to the original protocol (Buckeridge et al. 1999) , those Wve fractions are enriched with tonoplast, ER, Golgi, mitochondria, and plasma membrane, speciWcally. Here, only fractions 3, 4, and 5 were further characterized and used for the localization studies. These three fractions were diluted in buVer H to sucrose content below 15% and centrifuged again at 100,000g for 50 min. The pellet fractions were resuspended in buVer H without sucrose. Protein concentrations were determined using the Micro BCA kit from PIERCE (Rockford, IL).
Expression of polypeptides P2 and P3 in E. coli cells
The DNA sequence encoding the Wrst 272 amino acids of AtCSLD2 (fragment P2) was ampliWed from Arabidopsis genomic DNA using primers KEE919 (5Ј-CCTACATATG GCATCTAATAAG-3Ј) and KEE921 (5Ј-TCATGAATT CTTGGGCCTCCAT-3Ј). The DNA sequence encoding the Wrst 188 amino acids of AtCSLD3 (fragment P3) was ampliWed from Arabidopsis genomic DNA using primers KEE920 (5Ј-TTAGCATATGGCGTCTAATAAT-3Ј) and KEE922 (5Ј-CTGCTTGTTGTTCTCGAGCAAA-3Ј). PuriWed PCR products were inserted into pET28a via NdeI and EcoRI for the DNA fragment encoding P2, and via NdeI and XhoI for the DNA fragment encoding P3. The identities of constructs encoding peptides P2 and P3 were conWrmed by restriction digestion and sequencing. Peptide fragments P2 and P3 were expressed in E. coli BL21 (DE3) cells according to the manufacturer's guidelines (pET System Manual, Novagen, Madison, WI). Total soluble proteins were extracted from 100 ml of E. coli cultures expressing each construct after 4 h induction with IPTG.
Generation and puriWcation of polyclonal antibodies directed against AtCSLD2
AtCSLD2-speciWc peptide IQEPGRPPAGHSVKFAQ(C), corresponding to a region near the N-terminus (aa20-aa36), was synthesized and conjugated with keyhole limpet hemacyanin (KLH) for polyclonal antibody production in rabbits (Alpha Diagnostic International Inc., San Antonio, TX, USA). The polyclonal antibodies were aYnity puriWed with the same peptide immobilized on the SulfoLink coupling gel (PIERCE, Rockford, IL, USA) according to the manufacturer's directions.
SDS-PAGE and immunoblotting
All SDS-PAGE and immunoblotting procedures followed standard protocols (Harlow and Lane 1988) . Antibody against PMA2 (Morsomme et al. 1998 ), a Nicotiana plumbaginifolia plasma membrane H + -ATPase, was a gift from Dr. Marc Boutry (Université Catholique de Louvain, Louvain-la-Neuve, Belgium). Antibodies against TGN marker SYP61 (Sanderfoot et al. 2000) , PVC marker SYP21 (Sanderfoot et al. 1999) , TGN-PVC marker ELP (Ahmed et al. 1997) and ER marker SEC12 (Bar-Peled and Raikhel 1997) were gifts from Dr. Natasha Raikhel (University of California, Riverside). Antibody against alternative oxidase, a gift from the late Dr. Lee McIntosh (Michigan State University), is a monoclonal antibody against the Sauromatum guttatum alternative oxidase located in mitochondria (Elthon et al. 1988) . Rabbit antibody against XT1 was generated by Dr. Ahmed Faik (unpublished data) using a 17-kD fragment of the Arabidopsis XT1 protein that was expressed in E. coli.
Marker enzyme assays
The assay for -glucan synthase II (callose synthase, GS II) activity was modiWed from existing protocols (White et al. 1993; Konishi et al. 2001) . The reaction mixture contained 50 mM Hepes KOH, pH 7.0, 1 mM UDP-Glc, 5 mM CaCl 2 , 4.36 M UDP-[ 14 C]Glc (305.9 mCi/mmol). Reactions were carried out at room temperature for 45 min. XyG carrier (5 l of a 1% solution) was added to each reaction before 750 l of 70% ethanol was added to stop the reactions. Reaction products were precipitated at room temperature for 30 min and washed three times with 70% ethanol by mixing, followed by centrifugation at 12,000g for 5 min. The pellet was then air dried and resuspended in 200 l H 2 O for scintillation counting.
For XyG FUTase activity assays, microsomal membranes were solubilized with 1% Triton X-100 for 15 min on ice immediately before enzyme assays, unless solubilization of samples was not required. Assay reactions were carried out in volumes of 50 l, including 10 l of solubilized P100 membranes (9 l P100 sample plus 1 l 10% Triton X-100), 20 l of 2.5£ reaction buVer (100 mM HEPES KOH, pH 6.8, 0.5 M sucrose, 2.5 mM DTT, 2.5 mM MgCl 2 ), 10 l of 1% tamarind seed XyG and 2.5 l (diluted to 10 l with H 2 O before use) of GDP 14 C-fucose (10 Ci/ml and 271 mCi/mmol) (NEN Life Science Products, Inc.). Reactions were carried out at room temperature and stopped by the addition of 1 ml of 70% ethanol. Products of the enzyme assays were precipitated at 4°C or room temperature for at least 2 h and washed three times with 70% ethanol. After the last washing, the pellet was brieXy air dried and resuspended in 200 l H 2 O for scintillation counting.
Proteinase K protection assay
Membrane vesicles enriched in Golgi were puriWed from 20 g of suspension-cultured cells according to the protocol described above, and resuspended in 0.6 ml of buVer H without the addition of protease inhibitors. Equal amounts (90 l) of puriWed Golgi-rich vesicles were then incubated with 0, 200, and 400 g/ml proteinase K (Roche, Penzberg, Germany) with or without the addition of 1% Triton X-100 for 30 min at 25°C. The reactions were stopped by the addition of 5 l of 200 mM PMSF and left on ice. From each reaction, a 9-l aliquot was used for a XyG FUTase assay and a 30-l aliquot was analyzed by SDS-PAGE and immunoblotting.
Construction and localization of AtCSLD2-GFP
A DNA fragment cD2tmd encoding AtCSLD2 peptide from aa890 to aa1145 (end) containing the predicted C-terminal transmembrane domains was ampliWed through PCR reaction using primers D2d (upstream, 5Ј TTTTCACTAGT AACAACGCTCTTC 3Ј, SpeI) and D2b (downstream, 5Ј TCAACGGTACCTGGAAAACTGAA 3Ј, KpnI). This fragment was inserted into GFP expression vector GFPc (a gift from Dr. Shuocheng Zhang, Michigan State University) downstream of the encoded GFP protein via SpeI and KpnI to make the construct GFP-cD2tmd. A DNA fragment nD2tmd encoding AtCSLD2 peptide from aa1 to aa380 containing the predicted N-terminal transmembrane domains was ampliWed through RT-PCR reaction using primers D2e (upstream, 5Ј AAGTTGGATCCTAACTA TGGCAT 3Ј, BamHI) and D2f (downstream, 5Ј TCCTTGG ATCCTGAACTCGCCAGAACCAGCAGCGGAGCCAG CGGAACCGGTGGCACGATTAATCGGGCATAGCTT 3Ј, BamHI). This fragment was inserted into construct GFP-cD2tmd in front of the encoded GFP protein via BamHI, to make the Wnal construct nD2tmd-GFP-cD2tmd.
Plasmid nD2tmd-GFPc-cD2tmd and ST-DsRed (gift from Dr. Federica Brandizzi, Michigan State University), or plasmid GFPc plus ST-DsRed were introduced into onion epidermal cells using biolistic bombardment according to Zhang et al. (2001) . After being kept in the dark for 16-20 h, the onion peels were observed by means of an upright laser-scanning confocal microscope (Zeiss LsM510 META; Zeiss) according to Hanton et al. (2007) .
Results
Expression of AtCSLD genes
To investigate the localization of proteins encoded by AtCSLD genes, we chose to start with AtCSLD2 and AtCSLD3 because of their expression patterns. These two genes showed higher levels of expression than other members of the AtCSLD subfamily and their expression patterns were similar to each other based on analysis of the EST database from the GenBank and MPSS database (http:// mpss.udel.edu/at/). Furthermore, RT-PCR reactions using RNAs isolated from various tissues of Arabidopsis conWrmed the conclusion that AtCSLD2 and -D3 are expressed at higher levels than other AtCSLD genes and their expression patterns were similar to each other (Zeng 2004 ).
Generation, puriWcation, and characterization of antibodies against AtCSLD2
To explore the location of AtCSLD proteins, we generated and characterized polyclonal antibodies directed against peptides derived from AtCSLD2 or -D3. Because the antibody against the AtCSLD3-speciWc peptide did not recognize a speciWc protein from Arabidopsis extracts under conditions of the strategy described below, we selected AtCSLD2 to represent the AtCSLD family for our studies.
To produce a polyclonal antibody that speciWcally recognized AtCSLD2, we used as antigen a short peptide of 18 aa from the N-terminus (the antigen peptide's position is indicated in Fig. 1 ). We performed aYnity puriWcation of the antibodies using immobilized antigenic peptide. To characterize the puriWed antibodies, we expressed in Escherichia coli a polypeptide fragment, P2, containing the N-terminal 272 amino acids from AtCSLD2 (Fig. 1) ; and a polypeptide fragment, P3, containing a similar region, the N-terminal 188 aa from AtCSLD3. Neither of the fragments contained any of the predicted transmembrane domains of the corresponding full-length proteins (see Fig. 1 ). The expression of P2 and P3 in E. coli was conWrmed by SDS-PAGE followed by protein staining (Fig. 2a) and immunoblotting using antibodies against the 6£ His tag (Fig. 2b) . When tested on the E. coli extracts containing fragment P2 or P3, the peptide antibody against AtCSLD2 recognized only the expressed AtCSLD2 fragment P2 but not P3, which was derived from the equivalent region of AtCSLD3 (Fig. 2c) . Because the AtCSLD3 protein is the closest homolog of the AtCSLD2 protein, we concluded that this antibody is speciWc for AtCSLD2. Other smaller proteins that were detected on the immunoblots were probably degradation products of P2 (Fig. 2c) .
Three proteins were detected when the puriWed anti-D2-peptide antibodies were used to probe proteins from an Arabidopsis S10 fraction (Fig. 3a, signals 120 , 90, and 30). All three signals disappeared when the puriWed antibodies were incubated with extracts from E. coli cells expressing fragment P2, before they were used for immunoblotting against Arabidopsis proteins. E. coli extracts containing fragment P3 did not show such an eVect (data not shown); therefore, all three proteins (signals 120, 90, and 30) contained antigenic epitopes that can be recognized by the anti-peptide antibodies.
When the S10 proteins were further fractionated into S100 (soluble) and P100 (microsomal membrane) fractions, signal 90 was mainly associated with the S100 fraction and therefore likely to be a soluble protein (Fig. 3a) . Although both signals 120 and 30 were associated with the P100 fraction, only signal 120 was of the proper molecular size to represent AtCSLD2 (about 120 kD) (Fig. 3a) . AtCSLD2 is predicted to have eight transmembrane domains (Fig. 1) , and therefore should be an integral membrane protein.
Because only signal 120 was associated with microsomal membranes and had a molecular mass similar to that predicted for AtCSLD2 (120 kD), we concluded that signal 120 likely represents AtCSLD2 proteins (Fig. 3) . Furthermore, when vesicles enriched in Golgi membranes were prepared from Arabidopsis cell suspension cultures, only signal 120 was detected with the puriWed antibody against AtCSLD2 (Fig. 3b) .
To Wnd out what proteins signals 90 and 30 might represent, we searched the Arabidopsis protein sequence 288-310, 323-341, 923-945, 952-974, 993-1015, 1046-1064, 1079-1097, 1110-1128) . Peptide 20-36 (small gray striped box) was the antigen for producing antibodies. Peptide 1-272 (large gray box underneath) was expressed in E. coli with 6ЈHis tag as P2. c database at the National Center for Biotechnology Information (NCBI) using program BlastP searching for short nearly exact matches, with the sequence of the D2-speciWc antigen peptide as query. We identiWed ten proteins as having a region of two to six amino acids identical with the AtCSLD2-speciWc antigen peptide (data not shown). One of these ten proteins, which contained Wve sequential amino acids identical to the D2-speciWc antigen peptide, was predicted to have a molecular mass of 83 kD and no transmembrane domain. Another, with a stretch of four identical amino acids, was predicted to be 36 kD with a single transmembrane domain. No other proteins have a predicted molecular mass closer to that observed for signals 90 or 30. Although these two predicted proteins may give rise to the detected signals, we chose not to pursue this issue further.
AtCSLD2 is an integral membrane protein
As noted above, sequence analysis predicted that AtCSLD2 protein contains eight transmembrane domains (Fig. 1) .
After sequential centrifugation at 10,000g and at 100,000g, the majority of signal 120 was present in the P100 membrane fraction (Fig. 3a) , indicating that signal 120, presumably representing AtCSLD2, was associated with membranes. To investigate whether the putative AtCSLD2 behaved as an integral membrane protein or as a peripheral membrane protein, we treated microsomal membranes from the P100 fraction with various reagents that aVect the association of peripheral proteins with membranes (Fig. 4) . Our results showed that the antigenic protein could not be removed from microsomal membranes by 2 M Urea, 1 M NaCl, 0.1 M Na 2 CO 3 , or 0.2% Triton X-100, all of which can dissociate peripheral membrane proteins. Only 0.2% SDS completely solubilized the antigenic protein from the microsomal membranes, indicating that the putative AtCSLD2 was an integral membrane protein (Fig. 4) . We monitored several control proteins in this experiment to determine whether the solubilization procedure would yield the expected results. PMA2 is a plasma membrane H + -ATPase with multiple transmembrane domains and a predicted topology similar to AtCSLD2, with four transmembrane domains near the N-terminus and six close to the C-terminus (Morsomme et al. 1998 ). In our experiment, PMA2 was also removed only by 0.2% SDS and behaved just like AtCSLD2 (Fig. 4) . Arabidopsis XyG xylosyltransferase 1 (XT1) is predicted to be a type II integral membrane protein (Faik et al. 2002) . XT1 was completely Equal amounts of protein from P100 fraction prepared from hydroponically grown Arabidopsis plants were incubated on ice for 30 min with buVer alone, or with buVers containing 2 M Urea, 1 M NaCl, 0.1 M Na 2 CO 3 , 0.2% Triton X-100, or 0.2% SDS, and separated again as S100 and P100 fractions by centrifugation at 100,000g for 1 h. Pellets were resuspended in the same volume of buVer as the supernatant. Equal volumes of each fraction were analyzed by SDS-PAGE and immunoblotting was performed using antibodies against AtCSLD2, plasma membrane marker PMA2, Golgi markers XT1, TGN marker SYP61, and ER marker SEC12. S supernatant fractions; P pellet fractions AtCslD2 AtSEC12 AtSYP61 PMA2 AtXT1 S P S P S P S P S P S P Buffer 2M Urea 1M NaCl 0.1M Na 2 CO 3 0.2% Triton 0.2% SDS solubilized only by 0.2% SDS, but trace amounts were also solubilized by all the other reagents used, except with the buVer alone (Fig. 4) . Thus, XT1 was also an integral membrane protein but it may not be as tightly associated with the membranes as are AtCSLD2 and PMA2. Arabidopsis SEC12 is an ER-associated integral membrane protein that can be removed from membranes only by ionic or nonionic detergents but not by other treatments such as urea, salt, or alkaline conditions (Bar-Peled and Raikhel 1997). The behavior of SEC12 (Fig. 4) was the same as observed before (Bar-Peled and Raikhel 1997) and this protein served as a valuable control here. SEC12 also demonstrated a weaker association with the membranes; in addition to nearly complete solubilization by 0.2% SDS, SEC12 was also largely solubilized by 0.2% Triton X-100. SYP61 is a trans-Golgi network (TGN) protein with a single transmembrane domain near its C-terminus (Sanderfoot et al. 2000) . It also showed a weaker association with membranes when compared with AtCSLD2 or PMA2, as SYP61 was also removed from the membrane by 0.2% Triton X-100 (Fig. 4) .
AtCSLD2 was not a plasma membrane protein, as revealed by two-phase partitioning
To localize AtCSLD2 to a speciWc cellular compartment, we used three diVerent fractionation procedures. We Wrst tried to determine whether AtCSLD2 was located at the plasma membrane. An aqueous two-phase partitioning method that enriches the plasma membrane in the upper phase and most other cellular membranes in the lower phase was employed with three consecutive partitioning steps (Fig. 5) . The upper and lower phases from the third partitioning (U3 and L3, respectively) were analyzed for XyG fucosyltransferase (FUTase) and -glucan synthase II (GS II) activity to conWrm the eVect of partitioning (Fig. 5a) . U3 showed about fourfold higher speciWc activity of GS II than L3 (Fig. 5a ), indicating that the upper phase was enriched for plasma membrane. At the same time, about three times higher speciWc activity of XyG FUTase was detected in L3 than in U3 (Fig. 5a) , indicating an enrichment of Golgi vesicles in L3. All phases were then analyzed by immunoblotting to locate AtCSLD2 and the Golgi marker protein XT1, TGN marker protein SYP61, pre-vacuolar compartment (PVC) marker protein SYP21, TGN-PVC marker protein ELP, plasma membrane marker protein PMA2, and ER marker protein SEC12 (Fig. 5b) . At the end of the third partitioning, AtCSLD2 was found primarily in the lower phase, which also contained markers derived from Golgi, TGN, PVC, and ER. Furthermore, we examined the marker proteins for mitochondria (alternative oxidase, AOX) and chloroplast (AtToc75), and found that they both were associated with the lower phase (data not shown). On the other hand, the plasma membrane marker PMA2, partitioned predominantly into the upper phase (Fig. 5b) . From these observations, we concluded that AtCSLD2 was not localized in the plasma membrane.
AtCSLD2 migrated diVerently from the plasma membrane marker but similar to Golgi markers during linear sucrose gradient centrifugation Next we sought to determine which compartment within the endomembrane system contained AtCSLD2. Because of the similarity shared between AtCSLD and AtCESA . U1 and L1 fractions are the upper and lower phases after Wrst partitioning. U2 and L2Ј, or U2Ј and L2 are derived from the second partitioning of fractions U1 or L1, respectively. U3 and L3Ј, or U3Ј and L3 were derived from the third partitioning of fractions U2 or L2, respectively. a Relative speciWc activity of GSII and XyG FUTase in fractions U3 (white bars) and L3 (gray bars). The absolute speciWc activity measurements showed diVerences between replicates, but the ratios of speciWc activity between U3 and L3 were always very similar. The graph shows the average ratio derived from three experiments with standard errors. b Aliquots of equal volume from each fraction were analyzed by SDS-PAGE and immunoblotting with antibodies against marker proteins PMA2 (plasma membrane), XT1 (Golgi), SYP61 (TGN), ELP (TGN-PVC), SYP21 (PVC) and SEC12 (ER). Equal amounts of protein were also taken from fractions U3 and L3 for similar analysis. Data shown here are from a single experiment with protein samples extracted from suspension-cultured cells. Two other independent experiments gave similar results proteins, we believe that AtCSLD2 proteins are not likely to be located in mitochondria, plastids, or nuclei. As additional evidence against a nuclear localization, the elimination of nuclei during the Wrst step of protein preparation for all experimental procedures (see "Materials and methods") did not signiWcantly reduce the AtCSLD2 signal in subsequent immunoblots (Figs. 3, 4 , 5, 6, 7, 9). Later on, when more reWned membrane preparations were used and most plastids were removed due to their high density, a dramatic decrease or even total loss of signals was observed for chloroplast marker proteins Toc75 and Tic40 (data not shown). However, AtCSLD2 proteins could still be detected as before (Figs. 6, 7, 9) , indicating that AtCSLD2 proteins are not likely to be located in plastid membranes.
Sedimentation centrifugation through a linear sucrose density gradient was employed in an attempt to resolve diVerent membranes such as the ER, Golgi, PVC, and plasma membrane. As a Wrst step of enrichment, crude microsomal membranes from Arabidopsis suspensioncultured cells were collected from the interface of a step gradient containing 15 and 50% sucrose. The membrane vesicles from the interface were recovered and further fractionated on a density gradient from 30 to 50% sucrose. After centrifugation, the sucrose density gradient was nearly linear (Fig. 6a) . We analyzed the fractions using enzyme assays and immunoblots to detect marker enzymes that could help identify the vesicles derived from various organelles. XyG FUTase activity, a Golgi marker, peaked in fractions 6 and 7 (Fig. 6a) . Immunoblotting demonstrated that XT1, another Golgi marker, was detected in the same fractions (Fig. 6b) , leading to the conclusion that maximal enrichment of Golgi membranes was obtained in these fractions. AtCSLD2 was distributed most abundantly in fractions 4-9 (Fig. 6b) , which overlaps with the Golgi markers XyG FUTase and XT1, but with a broader distribution. All of the other markers were signiWcantly diVerent from the pattern shown by AtCSLD2. The plasma membrane marker, PMA2, was broadly distributed throughout the gradient with a broad (Fig. 6b) . The distribution of PMA2 detected by immunoblot coincided relatively well with the pattern of the GSII activity distribution in the gradient (Fig. 6a) . Meanwhile, the TGN-PVC marker ELP had the highest abundance in fractions 8 and 9, which was diVerent from the distribution pattern of either AtCSLD2, or the Golgi markers XyG FUTase and XT1 (Fig. 6b) . Finally, the PVC marker protein SYP21 and the ER marker SEC12 both had a broader distribution pattern that seemed to be a smear throughout the gradient (Fig. 6b) . Repeated attempts to detect TGN marker SYP61 in linear sucrose gradients failed for reasons that we do not understand (data not shown). Therefore, it seemed that AtCSLD2 is more likely to be located at the Golgi instead of other endomembranes, but has a diVerent distribution pattern through the Golgi cisternae than the XyG FUTase or XT1.
AtCSLD2 protein was localized in Golgi-rich vesicles during Xoatation sucrose gradient centrifugation Because eVorts to localize AtCSLD2 using linear sucrose gradients were not conclusive, we sought an independent approach to this problem. As a third method to investigate the localization of AtCSLD2, we isolated microsomal membranes from Arabidopsis suspension-cultured cells and fractionated via Xotation on a sucrose step gradient (Fig. 7a) . We evaluated the enrichment of Golgi and plasma membrane vesicles by performing XyG FUTase and GS II activity assays, respectively (Fig. 7b) . The speciWc activity of XyG FUTase in the Golgi-rich fraction (fraction 3) was more than 75 times greater than that in the starting material (Fig. 7b) .
Fraction 5 was depleted in Golgi membrane; its speciWc activity for XyG FUTase was only about 7% of that in fraction 3. On the other hand, the GS II speciWc activity was similar in fractions 4 and 5 (Fig. 7b) . The Golgi enriched membranes (fraction 3) showed some incorporation of radiolabeled glucose during GS II activity assays (Fig. 7b) . However, the GSII activity recorded for fraction 3 may not reXect its true level because when reactions were carried out for 45 versus 15 min, the radiolabel incorporation did not increase as expected (data not shown). In contrast, during GSII assays with other fractions, the incorporation of radiolabeled glucose increased signiWcantly when assayed for 45 min instead of 15 min (data not shown). When equal amount of proteins from each fraction were used for immunoblots (Fig. 7c) , we noticed that TGN marker protein SYP61 and Golgi marker protein XT1 were found almost exclusively in fraction 3 (Fig. 7d) , whereas the plasma membrane marker protein PMA2 was detected mainly in fraction 5 (Fig. 7d) , with small amounts in fractions 3 and 4. Taken together, these results supported the conclusion that fraction 3 was enriched in Golgi complex and fraction 5 was enriched in plasma membrane. Fraction 4, on the other hand, not only contained a mixture of these two membranes, but also was enriched in mitochondria, as demonstrated by the presence of the marker protein alternative oxidase (Fig. 7d) . The majority of AtCSLD2 was detected in fraction 3 (Fig. 7d) , leading us to conclude that AtCSLD2 was located in the Golgi-rich vesicles. Furthermore, the ER was distributed almost equally among fractions 3, 4 and 5, as revealed by the distribution pattern of ER marker protein SEC12 (Fig. 7d) . From these observations, we concluded that AtCSLD2 was not likely located at the ER membrane. However, it was not possible to resolve Golgi and TGN using this procedure because the Golgi marker XT1 and the TGN marker SYP61 showed similar distribution patterns (Fig. 7d) . We noticed that one plasma membrane marker, the GSII activity, had an almost equal distribution between fractions 4 and 5 (Fig. 7b) , whereas another plasma membrane marker, the PMA2 protein, was detected mainly in fraction 5 by immunoblotting (Fig. 7d) . This observation may indicate the presence of multiple enzyme activities that catalyzed the polymerization of UDP-glucose and contributed to the readings recorded as GSII activity.
AtCSLD2-GFP colocalized with ST-DsRed at Golgi vesicles when transiently expressed in onion epidermal cells
To obtain a diVerent line of evidence for the localization of AtCSLD2 proteins, we constructed a AtCSLD2-GFP fusion protein by replacing the predicted hydrophilic catalytic domain of AtCSLD2 (amino acids 381-889, Fig. 1 ) with an in-frame GFP protein while retaining all of the predicted transmembrane domains ("Materials and methods"). This fusion protein AtCSLD2-GFP was transiently expressed in onion epidermal cells together with a Golgi marker protein ST-DsRed (Saint-Jore et al. 2002) . Confocal Xuorescent microscopy showed that most of the signals from AtCSLD2-GFP proteins overlapped with signals from ST-DsRed located on Golgi vesicles (Fig. 8b) . Meanwhile the GFP protein itself showed a very diVerent localization pattern when coexpressed with ST-DsRed as control (Fig. 8a) .
The AtCSLD2 N-terminus was not protected by the Golgi membrane during proteinase K treatment To evaluate the topology of AtCSLD2 within the Golgi membrane, we used a proteinase K protection assay to determine availability of the N-terminus of AtCSLD2. Vesicles enriched in Golgi complex membranes were subjected to proteinase K treatment, then assayed for XyG FUTase activity and resolved on SDS-PAGE for immunoblotting. XyG FUTase activity is a latent Golgi activity because permeabilization of the Golgi membranes by detergent is required for measurement of its activity (Hanna et al. 1991; WulV et al. 2000) . Therefore, we used the XyG FUTase activity as a marker for the inside of the Golgi complex membrane.
We Wrst used XyG FUTase activity assays to validate the intactness and orientation of the Golgi vesicle preparation during the proteinase K treatment protocols. By comparing the XyG FUTase activity levels from Golgi vesicles with or without including Triton X-100 in the enzyme activity assay reactions, we observed that greater than 90% of the activity was latent and therefore concluded that less than 10% of the Golgi vesicles were inside out or broken (data not shown). We determined that under our assay conditions proteinase K did not penetrate the Golgi membranes because enzyme treatment destroyed only a very small amount of XyG FUTase activity when the Golgi vesicles were not treated with Triton X-100 (Fig. 9a, reactions 2 and 3) . On the other hand, when the Golgi vesicles were permeabilized with detergent prior to proteinase K treatment, almost all of the XyG FUTase activity was degraded (Fig. 9a, reactions 5 and  6 ). In addition to XyG FUTase, many other proteins were also protected from degradation when Golgi vesicles were not permeabilized during proteinase K treatment (Fig. 9b,  reactions 2 and 3) . Presumably, those proteins also face the inside of the Golgi vesicles. However, an almost complete degradation of the proteins was achieved when the Golgi vesicles were treated with Triton X-100 during proteinase K treatment (Fig. 9b, reactions 5 and 6) . Using the treatment conditions described above, we examined the presence of AtCSLD2 and XT1 by immunoblot (Fig. 9c) . Our earlier data (Figs. 4, 5, 6, 7) showed that XT1 was a Golgi-localized integral membrane protein, and we used this result as a control. XT1 is predicted to be a type II transmembrane protein with a single transmembrane domain near its N-terminus and facing the Golgi lumen (Faik et al. 2002) . The antibody against XT1 used in this work was generated against the large domain after the Nterminal transmembrane domain (A. Faik and K. Keegstra, unpublished data) . Therefore, if XT1 is facing the Golgi lumen, it should be protected from proteinase K when Golgi vesicles are not permeabilized. Indeed, we saw no change in signal intensity when Golgi vesicles were treated with proteinase K without the addition of Triton X-100 (Fig. 9c, reactions 2 and 3) . However, when Triton X-100 was added to the Golgi vesicles, XT1 was completely degraded by proteinase K (Fig. 9c, reactions 5 and 6) .
Immunoblot signals for AtCSLD2 showed a diVerent pattern (Fig. 9c) . AtCSLD2 was completely degraded by proteinase K treatment regardless of whether or not Triton X-100 was present in the reaction mixture (Fig. 9c , reactions 2, 3, 5, and 6). From this observation, we concluded that the antigenic region (the extreme N-terminus) of AtCSLD2 was located on the outer surface of the Golgi membrane, facing the cytosol. Alternatively, if the N-terminus of AtCSLD2 were inside the Golgi lumen, then the closest cleavage site accessible to proteinase K would have been right after the Wrst transmembrane domain (Fig. 1) . In this case, an AtCSLD2 peptide from amino acid residues 1 to 287 with a predicted molecular mass of around 32 kD should have been detected by our antibody as the degradation product. What we saw from the immunoblot, however, was a total disappearance of signal for the full-length AtCSLD2, and no appearance of new signals with smaller molecular mass (Fig. 9c) .
The program TMHMM predicts that AtCSLD2 has eight transmembrane domains ( Fig. 1) : two are located between the N-terminal peptide used as antigen and the large hydrophilic domain (Fig. 1) . If this prediction were correct, our data supported the conclusion that the large hydrophilic domain of AtCSLD2 faced the cytosol.
Discussion
Although genetic approaches have been used successfully to analyze the functions of many AtCESA genes (Arioli et al. 1998; Taylor et al. 1999 Taylor et al. , 2000 Fagard et al. 2000; Scheible et al. 2001; Burn et al. 2002; Desprez et al. 2002; Zhong et al. 2003) and some genes involved in the biosynthesis of matrix polysaccharides (Bouton et al. 2002; Iwai et al. 2002; Vanzin et al. 2002; Madson et al. 2003) , genetic studies for CSL genes have not been as successful in determining their biochemical functions. So far, mutations in only a few CSL genes have yielded speciWc phenotypes, including AtCSLA7 (Goubet et al. 2003) , AtCSLA9/rat4 (Zhu et al. 2003) , AtCSLD3/kojak (kjk) (Favery et al. 2001 ; Fig. 9 AtCSLD2 is not protected by Golgi membranes during proteinase K treatment, whereas XT1 proteins and XyG FUTase activity are. The samples and reaction conditions are all the same in a, b, and c. Equal amounts of Golgi-rich vesicles were treated with 0 g/ml (reactions 1 and 4), 200 g/ml (reactions 2 and 5), or 400 g/ml (reactions 3 and 6) proteinase K with (reactions 4, 5, and 6) or without (reactions 1, 2, and 3) the presence of 1% Triton X-100. After treatment, equal amounts of samples were assayed for XyG FUTase activity in the presence of 1% Triton X-100 (a), visualized on SDS-PAGE with Coomassie Brilliant Blue staining (b), or subjected to immunoblot analysis with antibodies against XT1 and AtCSLD2 (c). Data shown are from a single experiment; two replicate experiments gave similar results. The percentage of inside-out Golgi complex vesicles is determined by comparing the XyG FUTase activity assayed with or without permeabilization of the membrane vesicles with 1% Triton X-100. In this case, the inside-out or unsealed vesicles constitute only 8.8% of the total Wang et al. 2001) , AtCSLD5 (Bernal et al. 2007) , and OsCSLD1 (Kim et al. 2007 ). However, none of the mutations have been linked to changes in speciWc sugar linkages within a speciWc cell wall polysaccharide and therefore the biochemical functions of these genes could not be determined from these studies. Furthermore, our attempt to suppress multiple AtCSLD genes using an RNAi approach did not yield changes in any speciWc sugar linkages (Zeng 2004) . Therefore, we conducted localization and topological studies of AtCSLD proteins to Wnd out whether this information would oVer some hints about their biochemical functions.
In our present study, we used three diVerent membrane fractionation procedures to monitor the behavior of AtCSLD2 proteins during cell fractionation. In the twophase partitioning experiment, AtCSLD2 and the plasma membrane marker protein PMA2 were partitioned into diVerent phases, which led us to conclude that AtCSLD2 is not located in the plasma membrane, but rather in some portion of the endomembrane system. Because AtCSLD2's distribution pattern in the linear sucrose density gradient is very diVerent from the PVC marker protein SYP21, the TGN-PVC marker protein ELP, and the ER marker protein SEC12, we concluded that AtCSLD2 was not located in any of these fractions. On the other hand, the distribution pattern of AtCSLD2 matched best with that of Golgi marker protein XT1 and marker enzyme activity of XyG FUTase in all three membrane fractionation procedures (Figs. 5, 6, 7) . Therefore, we concluded that AtCSLD2 most likely resides in the Golgi apparatus. We noted that the ER marker protein SEC12 was always detected within multiple membrane fractions (Figs. 5, 6, 7) . This characteristic may indicate a physical closeness of the ER with other membrane compartments or the diYculty of separating ER membranes from other endomembranes with the techniques employed in our studies.
In addition to the cellular membrane fractionation approaches, the transient expression of AtCSLD2-GFP fusion protein in onion epidermal cells showed its localization in Golgi vesicles more directly. Bioinformatic tools helped to predict that AtCSLD2 proteins have eight transmembrane domains, with two of them located close to the N-terminus and the other six close to the C-terminus (Fig. 1) . The region between these two groups of transmembrane domains of AtCSLD2 is the predicted catalytic domain. In our AtCSLD-GFP fusion protein, this catalytic domain was replaced by the GFP, with all the predicted transmembrane domains of AtCSLD2 kept intact. This design of GFP fusion protein therefore kept the relative positions of all the transmembrane domains similar to the endogenous AtCSLD2 proteins. The AtCSLD2-GFP fusion protein showed a localization pattern similar to a Golgi marker protein ST-DsRed, which has the transmembrane domain and the short cytoplasmic tail (52 amino acids) of the rat -2,6-sialyltransferase (ST) fused with DsRed (BD Clontech) and was shown to localize at the Golgi apparatus Saint-Jore et al. 2002) . Based on these results, we argue that AtCSLD2 proteins are most likely located in the Golgi. Our conclusion that AtCSLD2 was localized at the Golgi is consistent with Bernal et al.'s observation when they studied localization with N-terminal GFP fusion proteins of AtCSLD5 and AtCSLD3 (Bernal et al. 2007) .
Another important question regarding glycosyltransferases and glycan synthases concerns their topology within the membrane. Most glycosyltransferases are thought to be type II membrane proteins with a single membrane-spanning domain and a large hydrophilic domain facing the lumen of the Golgi (Keegstra and Raikhel 2001) . This topology has been experimentally demonstrated for the xyloglucan FUTase (WulV et al. 2000) , which was conWrmed again in the studies reported here (Fig. 9) . The substrate nucleotide sugars are proposed to be imported into the Golgi lumen by speciWc transporters, with the products accumulating in the Golgi lumen (Munoz et al. 1996; Neckelmann and Orellana 1998; WulV et al. 2000; Sterling et al. 2001) .
The topology of glycan synthases is a more complicated issue because of the presence of multiple transmembrane domains. It is widely accepted that cellulose synthase contains eight transmembrane domains that span the plasma membrane, and a large hydrophilic domain residing in the cytosol that presumably contains the active site (Delmer 1999) . In this case, cellulose accumulates on the outside of the plasma membrane, indicating that cellulose synthase acts not only as a polymerase, but also as a transporter. However, the exact topology of the CESA protein has not yet been conWrmed experimentally. Similarly, computer calculations predict the existence of multiple transmembrane domains in all of the CSL proteins (Richmond and Somerville 2000; Zeng 2004 ). CSLD, which has extensive sequence similarity to the CESA proteins, is predicted to have eight transmembrane domains by most of the on-line computer-based transmembrane domain prediction algorithms (Fig. 1) . However, its topology within the membrane remains unclear.
The large hydrophilic domain of AtCSLD proteins, which is proposed to contain the catalytic activity of the enzyme, may face either the cytosol or the Golgi lumen. If the Wrst case is true, the enzyme would function like cellulose synthase, using nucleotide sugars directly from the cytosol; and the polysaccharide product would be deposited on the other side of the membrane. If the second case is true, sugar nucleotides would be used in the lumen where the polysaccharide product accumulates; and transmembrane transport would be unnecessary (Scheible and Pauly 2004) .
Prior to our studies reported here, the only similar topology study was carried out on the maize mixed linkage (1-3), (1-4)--glucan synthase (Urbanowicz et al. 2004) . In that study, the pretreatment of Golgi membranes with increasing concentrations of proteinase K decreased the (1-3),(1-4)--glucan synthase activity accordingly. The catalytic domain of the (1-3),(1-4)--glucan synthase was thus proposed to be on the cytoplasmic face of the Golgi membranes, with extrusion of the growing polymer into the lumen of the Golgi. Therefore, topologically, the (1-3), (1-4)--glucan synthase behaves similarly to cellulose synthase.
In the topological study reported here, the N-terminus of AtCSLD2 was extremely sensitive to proteinase K treatment, regardless of whether or not Golgi vesicles were pretreated with Triton X-100. In contrast, both the XT1 protein and XyG FUTase activity were resistant to proteinase K treatment unless the Golgi vesicles were pretreated with Triton X-100. As noted above, using the program TMHMM, AtCSLD2 is predicted to have eight transmembrane domains, with two of them close to the N-terminus and the other six close to the C-terminus (Fig. 1) . Based on these results and the transmembrane domain predictions, we concluded that the N-terminus of AtCSLD2 faces the cytosolic side of Golgi complex membranes. Using the membrane topology model of AtCSLD2 shown in Fig. 1 , we deduced that the large hydrophilic loop containing the D,D,D,Q££RW motif also faces the cytosol. If correct, this conclusion would put AtCSLD2 into the same category topologically as the maize (1-3),(1-4)--glucan synthase and cellulose synthases, in regard to the mechanisms involved in the synthesis of respective polysaccharides.
The conclusion that the large hydrophilic loop containing the putative catalytic domain faces the cytosol is dependent upon a few assumptions that are relatively safe, but should be noted. The Wrst is that the membrane vesicles are sealed so that in the absence of detergent, the protease cannot gain access to the lumen of the vesicles. Because both the XT1 protein and XyG FUTase activity are resistant to protease digestion in the absence of detergent, it seems reasonable to assume that the vesicles are sealed. The second assumption relates to the model that predicts the number and location of the putative transmembrane domains. The program used here, TMHMM, is normally very reliable in predicting the location of transmembrane domains (Krogh et al. 2001) . In addition, when AtCSLD2 was analyzed for topology prediction by 17 diVerent programs at Aramemnon (http://aramemnon.botanik.uni-koeln.de/index.ep), 14 of them, including TMHMM and the consensus predictions, gave the same topology as that shown in Fig. 1 . Thus, the assumption regarding the transmembrane domain structure seems well supported, and it is reasonable to conclude that the N-terminus and the large hydrophilic domain of AtCSLD2 are on the same side of the membrane, i.e., the cytosolic side.
In summary, our data support the notion that AtCSLD2 is located at the Golgi membrane, but has a topology similar to cellulose synthase with the catalytic domain facing the cytoplasmic side of the Golgi. Nevertheless, we are still not able to predict the biochemical functions of AtCSLD proteins. On one hand, AtCSLD2 is located at the Golgi apparatus, based on the conventional concepts, and so likely functions as a non-cellulosic glycan synthase. Cellulose is believed to be synthesized at the plasma membrane and is directly incorporated into the wall, whereas the other polysaccharides are synthesized at the Golgi apparatus (Kimura et al. 1999) . Likewise, cellulose synthases have long been thought to be exclusively localized at the plasma membrane and other glycan synthases and glycosyltransferases are thought to be located in the Golgi.
On the other hand, very recent localization studies on KORRIGAN1, an endo-1,4--D-glucanase involved in cellulose synthesis, and AtCSLA6, suggest that cellulose synthases might not reside exclusively in the plasma membranes, but rather commute between the plasma membranes and endomembranes, including Golgi vesicles (Robert et al. 2005; Paredez et al. 2006) . Based on these observations and the Golgi localization of AtCSLD2 proteins shown by our study, a non-cellulosic function for AtCSLD proteins seems likely. However, because we did not explore the possibility of AtCSLD2 traYcking between Golgi and plasma membranes, we cannot rule out the possibility that our data represented no more than a small snapshot of the cellular distribution of AtCSLD2 proteins. Given diVerent physiological conditions, AtCSLD2 proteins might distribute diVerently among diVerent cellular compartments.
